News
- Author:
- Richard Mark Kirkner
Publish date: December 20, 2021
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a devic...
News
- Author:
- Richard Mark Kirkner
Publish date: December 7, 2021
Fast-track clinics are using vascular ultrasound to streamline diagnosis of giant cell arteritis, but the United States has a way to go to catch up...
News
- Author:
- Richard Mark Kirkner
Publish date: December 7, 2021
A cohort study of the Jackson Heart Study identified novel metabolites that may influence coronary heart disease ...
News
- Author:
- Richard Mark Kirkner
Publish date: December 6, 2021
Sleep apnea and other sleep disorders appear to elevate the risk for some types of cancer, but lower the risk in ...
News
- Author:
- Richard Mark Kirkner
Publish date: November 19, 2021
Rituximab doses as low as 200 mg were effective in treating rheumatoid arthritis, an extension study of a small trial in the Netherlands found.
News
- Author:
- Richard Mark Kirkner
Publish date: November 16, 2021
Analyses of the phase 3b/4 ORAL Surveillance trial results found independent factors for risk for major adverse cardiovascular events, cancer, and ...
News
- Author:
- Richard Mark Kirkner
Publish date: November 15, 2021
A phase 3 trial has found that rituximab is not superior to cyclophosphamide to induce remission in eosinophilic granulomatosis with polyangiitis.<...
News
- Author:
- Richard Mark Kirkner
Publish date: November 11, 2021
A trial found that immunosuppressed adults with autoimmune disease had a robust antibody response to the mRNA vaccine with no excess adverse events...
News
- Author:
- Richard Mark Kirkner
Publish date: November 9, 2021
A large cohort study reports that the cardiovascular benefits of statin use in people with rheumatoid arthritis outweigh the moderate diabetes risk...
News
- Author:
- Richard Mark Kirkner
Publish date: November 8, 2021
Early results of a randomized clinical trial show that a 6-month course of abatacept may delay or prevent progression to rheumatoid arthritis.
News
- Author:
- Richard Mark Kirkner
Publish date: October 19, 2021
A new American Heart Association policy statement recommends actions to improve care for people who have ST-segment elevation MI.
News
- Author:
- Richard Mark Kirkner
Publish date: September 23, 2021
Researchers in the Netherlands identified COVID-19–related stressors for people with Parkinson’s disease and the most vulnerable subgroups.
News
- Author:
- Richard Mark Kirkner
Publish date: September 23, 2021
A phase 3 trial reported that a new formulation of a botulinum toxin had a longer duration of effect with fewer side effects than existing injectio...
News
- Author:
- Richard Mark Kirkner
Publish date: September 23, 2021
Genetic studies in Parkinson’s disease have been heavily skewed to European populations, but a number of efforts aim to make study populations more...
News
- Author:
- Richard Mark Kirkner
Publish date: September 23, 2021
An extension study found that the synthetic medium-chain triglyceride triheptanoin improved brain energy and caudate atrophy in Huntington’s diseas...
